Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Change in Acquisitions & Divestments (2024 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with -$10.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments fell 290.21% year-over-year to -$10.9 million, compared with a TTM value of -$4.2 million through Sep 2025, down 171.91%, and an annual FY2024 reading of $1.3 million, changed N/A over the prior year.
  • Change in Acquisitions & Divestments was -$10.9 million for Q3 2025 at Kiora Pharmaceuticals, down from $5.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $6.2 million in Q1 2025 and bottomed at -$10.9 million in Q3 2025.